EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Humanized Murine Glioblastoma Models for Evaluation of Coxsackievirus Oncolytic Therapy

Yana D Gumennaya iD, Marat P Valikhov, Elizaveta R Naberezhnaya iD, Pavel O Vorobyev iD, Veronika V Vadekhina iD, Olga N Alekseeva iD, Anastasiia O Sosnovtseva, Dmitry V Kochetkov, Alesya V Soboleva, Leen Ibrahim, Stepan A Ionov, Gaukhar M Yusubalieva iD und 3 weitere

Cancers · 17.04.2026 · 18 (8) · 1280

DOI: 10.3390/cancers18081280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 17.04.2026. Verfasst von Yana D Gumennaya und 14 weiteren Autor:innen. Beteiligte Einrichtung: Engelhard Institute of Molecular Biology, Russian Academy of Science, 119991 Moscow, Russia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Glioblastoma remains the most lethal primary brain tumor in adults, and progress in oncolytic virotherapy is limited by the lack of immunocompetent models permissive to human-tropic viruses.

Methods

Here, murine CT-2A and GL261 glioma and B16 melanoma cell lines were engineered to express human Coxsackievirus and Adenovirus Receptor (CXADR) fused to tagBFP, generating “humanized” tumors that preserve parental growth characteristics while acquiring high susceptibility to group B Coxsackieviruses (CVBs) and adenovirus serotype 5.

Results

CXADR expression in CT-2A, GL261, and B16 cells markedly enhanced binding, internalization, and replication of CVBs in vitro, with the strongest effect observed for LEV14 (attenuated CVB5), which reached up to 105-fold higher viral titers in humanized cells compared with parental cells. Unchanged sensitivity to vesicular stomatitis virus indicated receptor-specific effects. Humanized CT-2A-CXADR-BFP and GL261-CXADR-BFP cells initiated aggressive subcutaneous and intracranial tumors in syngeneic C57BL/6 mice without signs of immune rejection, and histology and MRI confirmed invasive high-grade glioma phenotypes. In intracranial CT-2A-CXADR-BFP tumors, repeated intratumoral LEV14 administration induced extensive tumor necrosis and prolonged survival despite the rapid development of neutralizing antibodies. Systemic intravenous LEV14 dosing produced strong oncolytic activity against subcutaneous CT-2A-CXADR-BFP tumors, as demonstrated by pronounced tumor growth inhibition, long-lasting regression in a subset of animals with gliomas, and improved overall survival.

Conclusions

Collectively, these data establish CXADR-humanized models as versatile, immunocompetent platforms for evaluation of CXADR-dependent oncolytic enteroviruses.

Schlagwörter

Stichwörter der Autor:innen

CXADRCoxsackievirus B5LEV14enterovirusglioblastomaoncolytic virussyngeneic murine model

Autor:innen und Institutionen

  • Engelhard Institute of Molecular Biology, Russian Academy of Science, 119991 Moscow, Russia.
  • Moscow Center for Advanced Studies, Kulakova Str. 20, 123592 Moscow, Russia.
  • Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, 119034 Moscow, Russia.
  • Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies, Federal Medical and Biological Agency, 115682 Moscow, Russia.

ORCID-Profile: Yana D Gumennaya, Elizaveta R Naberezhnaya, Pavel O Vorobyev, Veronika V Vadekhina, Olga N Alekseeva, Gaukhar M Yusubalieva, Alexander V Ivanov

Förderung

  • Russian Science Foundation
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Gumennaya, Y. D., Valikhov, M. P., Naberezhnaya, E. R., Vorobyev, P. O., Vadekhina, V. V., Alekseeva, O. N., Sosnovtseva, A. O., Kochetkov, D. V., Soboleva, A. V., Ibrahim, L., Ionov, S. A., Yusubalieva, G. M., Ivanov, A. V., Chumakov, P. M., & Poteryakhina, A. V. (2026). Humanized Murine Glioblastoma Models for Evaluation of Coxsackievirus Oncolytic Therapy. Cancers, 18(8), 1280. https://doi.org/10.3390/cancers18081280

Vancouver

Gumennaya YD, Valikhov MP, Naberezhnaya ER, Vorobyev PO, Vadekhina VV, Alekseeva ON, et al. Humanized Murine Glioblastoma Models for Evaluation of Coxsackievirus Oncolytic Therapy. Cancers. 2026;18(8):1280. doi:10.3390/cancers18081280

BibTeX
@article{Gumennaya2026,
  author = {Gumennaya, Yana D and Valikhov, Marat P and Naberezhnaya, Elizaveta R and Vorobyev, Pavel O and Vadekhina, Veronika V and Alekseeva, Olga N and Sosnovtseva, Anastasiia O and Kochetkov, Dmitry V and Soboleva, Alesya V and Ibrahim, Leen and Ionov, Stepan A and Yusubalieva, Gaukhar M and Ivanov, Alexander V and Chumakov, Peter M and Poteryakhina, Anastasia V},
  title = {Humanized Murine Glioblastoma Models for Evaluation of Coxsackievirus Oncolytic Therapy},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {1280},
  doi = {10.3390/cancers18081280}
}
Kostenlos starten →